Quantikine Immunoassay Control Group 1
Quantikine Immunoassay Control Group 1 Summary
INTENDED USE & DESCRIPTION
For use as quantitative controls for the determination of cytokine concentrations in biological fluids. Concentrations have been assigned using R&D Systems’ Quantikine® kits. Controls are prepared in diluted porcine serum with preservatives. They contain recombinant human cytokines at low, medium and high concentrations. Controls are supplied lyophilized.
STORAGE & STABILITY
Unreconstituted Controls should be stored at 2-8 °C and are stable for at least 6 months from date of receipt. Depending on the analyte of interest, reconstituted controls may be stable when stored at ≤ -20 °C. Users should evaluate the frozen stability of the controls in their application or discard after use.
REAGENT PREPARATION
Reconstitute each vial with the volume of deionized or distilled water indicated in the chart provided in the product datasheet.
PROCEDURE & EXPECTED VALUES
Controls should be assayed in the same manner as unknown specimens.
Note: Do not activate controls when running TGF-β1. The acceptable ranges (±3 SD) for the analytes in these controls are printed in the product datasheet. Due to possible variations in techniques and methodologies, it is recommended that each laboratory determine its own target range. Laboratories using other test systems should establish their own acceptable ranges as these assays may produce different values.
TECHNICAL HINTS & LIMITATIONS OF THE PROCEDURE
• The ranges were determined using R&D Systems’ Quantikine kits. If expected values are not obtained, verify that the lot numbers on the vials correspond with the lot numbers listed above and the correct volume of deionized or distilled water was used for reconstitution of the controls.
• The results obtained with these controls depend upon several factors associated with methods and instrumentation. Test systems other than those supplied by R&D Systems may result in values that differ from those printed on the product datasheet.
Specifications
Product Datasheets
Citations for Quantikine Immunoassay Control Group 1
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
3
Citations: Showing 1 - 3
Filter your results:
Filter by:
-
Frailty Is Associated with Malnutrition-Inflammation Syndrome in Older CKD Patients
Authors: Molinari, P;Caldiroli, L;Abinti, M;Nardelli, L;Armelloni, S;Cesari, M;Castellano, G;Vettoretti, S;
Nutrients 2024-08-09
-
Exposure modality influences viral kinetics but not respiratory outcome of COVID-19 in multiple nonhuman primate species
Authors: AC Fears, BJ Beddingfie, NR Chirichell, N Slisarenko, SZ Killeen, RK Redmann, K Goff, S Spencer, B Picou, N Golden, CC Midkiff, DJ Bush, LM Branco, ML Boisen, H Gao, DC Montefiori, RV Blair, LA Doyle-Meye, K Russell-Lo, NJ Maness, CJ Roy
PloS Pathogens, 2022-07-05;18(7):e1010618. 2022-07-05
-
Sarcopenia is Associated with Malnutrition but Not with Systemic Inflammation in Older Persons with Advanced CKD
Authors: S Vettoretti, L Caldiroli, S Armelloni, C Ferrari, M Cesari, P Messa
Nutrients, 2019-06-19;11(6):. 2019-06-19
FAQs
No product specific FAQs exist for this product, however you may
View all ELISA FAQsReviews for Quantikine Immunoassay Control Group 1
Average Rating: 5 (Based on 6 Reviews)
Have you used Quantikine Immunoassay Control Group 1?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Filter by: